Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view.

@article{Schmidt2001RecommendationsOT,
  title={Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view.},
  author={Dieter Schmidt and Santiago Arroyo and Michel Baulac and Mogens Dam and Olivier Dulac and Mogens Laue Friis and Reetta K{\"a}lvi{\"a}inen and G{\"u}nter Kr{\"a}mer and J A van Parys and Bent Pedersen and Rajesh C. Sachdeo},
  journal={Acta neurologica Scandinavica},
  year={2001},
  volume={104 3},
  pages={
          167-70
        }
}
Extensive clinical use and a series of clinical trials have shown that oxcarbazepine is a valuable antiepileptic drug for the treatment of adults and children with partial onset seizures both in initial monotherapy, for conversion to monotherapy and as adjunctive therapy. The clinically recommended titration scheme for all forms of therapy in adults is to start with 150 mg/day at night and to increase by 150 mg/day every second day until a target dose of 900-1200 mg/day is reached. If necessary… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.

  • Clinical neuropharmacology
  • 2010
VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

In search of models for hepatic and placental pharmacokinetics

VIEW 9 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED